Fundz

Inherent Biosciences reported raising $1.51 Million in an initial SEC Form D filing

PRIVATEMay 31, 2023Late filing, first sale Aug 19, 2022

Amount Raised

$1.51 Million

$1.51 Million sold, per SEC Form D (first sale Aug 19, 2022)

Round Type

Seed

Salt Lake CityBiotechnologyHealth CareGeneticsTherapeutics

Quick answer

Inherent Biosciences raised $1.51 Million in a Seed round, dated August 19, 2022. Inherent Biosciences is based in Salt Lake City, Utah, United States.

How much did Inherent Biosciences raise?
Inherent Biosciences raised $1.51 Million in a Seed round on August 19, 2022.
What does Inherent Biosciences do?
Inherent Biosciences is pioneering epigenetic medicine for complex diseases.
Where is Inherent Biosciences based and how big is it?
Inherent Biosciences is based in Salt Lake City, Utah, United States.
Who are the decision-makers at Inherent Biosciences?
Fundz holds 1 contact at Inherent Biosciences, including the Co-founder, CEO . Names and contact details are shown to Fundz members.

Source: Fundz verified event record.

Who else raised in Genetics and Therapeutics around the same time

Companies in the same sectors as Inherent Biosciences that raised within 45 days of this round, from Fundz verified event records.

  • Photys Therapeutics raised $75M (Series A) on September 8, 2022.
  • MeiraGTx Holdings plc raised an undisclosed amount (Debt Financing) on August 3, 2022.
  • Elevation Oncology raised $50M (Debt Financing) on July 28, 2022.
  • Gamida Cell raised $25M (Funding Round) on September 28, 2022.
  • CLEARA Biotech B.V raised $2.5M (Seed) on September 28, 2022.
  • bioAffinity Technologies raised $7.7M (Post-IPO Equity) on September 28, 2022.

Who to call at Inherent Biosciences, and when

A new round usually means Inherent Biosciences is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day Inherent Biosciences raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Inherent Biosciences, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Inherent Biosciences. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Inherent Biosciences

Location

Salt Lake City, Utah, United States

About

Inherent Biosciences is pioneering epigenetic medicine for complex diseases. Gene dysregulation, a hallmark of complex disease, has been difficult to detect and treat, until now... Our epigenetic platform detects dysregulation across multiple genes and related pathways. We're pioneering a new category of diagnostics and therapeutics that leverage epigenetics, biology's inherent mechanism for gene regulation, to radically transform how we diagnose and treat complex diseases like infertility, autoimmune disease, autism, and other complex diseases. Our first products help patients suffering from infertility.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Inherent Biosciences raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

1 contact
Verified contactsAndy O., Co-founder, CEO hiddenSee plans and pricing
Predictive Intelligence
Strategic

ML-powered predictions for Inherent Biosciences's next move

See what Strategic adds

Inherent Biosciences raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.